Evidence map›Paper›PMID 40587502›Full record

ArticlePloS one2025

Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties.

Shafia Parveen, Shazia Iqbal, Saima Maher, Paul Wilson, Habib Nasir, Samreen Soomro, Shazia Nisar, Muhammad Imran, Musarat Riaz, Rabail Urooj and 7 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shafia ParveenDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Shazia IqbalDepartment of Chemistry, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Pakistan.
Saima MaherDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.ORCID 0000-0002-4269-6398
Paul WilsonDepartment of Chemistry, Warwick University, Coventry, United Kingdom.
Habib NasirDepartment of Chemistry, School of Natural Sciences, National University of Sciences and Technology, Islamabad, Pakistan.
Samreen SoomroDepartment of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.ORCID 0000-0002-5743-6652
Shazia NisarDepartment of Chemistry, University of Karachi, Karachi, Pakistan.
Muhammad ImranDepartment of Chemistry, Faculty of Science, King Khalid University, Abha, Saudi Arabia.
Musarat RiazDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Rabail UroojDepartment of Environmental Science, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Mah Ganj BakhshiDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Maria EssaDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Farah MukhtarDepartment of Chemistry, Sardar Bahadur Khan Women University Quetta, Quetta, Pakistan.
Attya BhattiDepartment of Biomedicine, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Hussnain A JanjuaDepartment of Industrial Biotechnology, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Amir FaisalDepartment of Biology, Syed Babar Ali School of Science and Engineering, Lahore University of Management Sciences, Lahore, Pakistan.
Arsalan SaleemDepartment of Biology, Georgia State University, Atlanta, Georgia, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the green synthesis of silver nanoparticles (AgNPs) using the medicinal plant Asplenium dalhousiae focusing on its bioactive chemical constituents as natural reducing agents. Aqueous, chloroform, and n-hexane extracts of the plant leaves were utilized in the nanoparticle synthesis process. The synthesized AgNPs were confirmed through UV-visible spectroscopy, showing absorption peaks at approximately 420 nm, 443 nm, and 439 nm. Fourier-transform infrared (FTIR) spectroscopy was used to recognize the functional groups in the plant extracts responsible for facilitating the reduction process. The morphological and structural characteristics of the synthesized nanoparticles were analyzed using Scanning Electron Microscopy (SEM) and X-ray Diffraction (XRD). These analyses revealed that the nanoparticles synthesized using the Aqueous, chloroform, and n-hexane extracts were predominantly spherical silver nanoparticles (AgNPs) with a crystalline structure and an average diameter of 46.98 ± 12.45 nm, as determined by SEM. The antibacterial efficacy of the synthesized AgNPs was evaluated against Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa at a concentration of 30 μg/ml. Among the tested nanoparticles, the AgNPs synthesized from the n-hexane extract exhibited the highest antibacterial activity, with zones of inhibition measuring 20.0 ± 1.8 mm for E. coli, 19.0 ± 1.2 mm for B. subtilis, and 19.5 ± 1.4 mm for P. aeruginosa. Additionally, the silver nanoparticles (AgNPs) from Asplenium dalhousiae demonstrated significant α-amylase inhibition, with 85.04% inhibition at 500 µg/ml, compared to Acarbose (90.84%) and the leaf extract (78.65%). The antioxidant activity of the synthesized AgNPs was assessed using the DPPH method, which confirmed their significant antioxidant properties alongside their antibacterial activity. The aqueous and n-hexane silver nanoparticles (AgNPs) showed strong cytotoxic activity with low IC50 values, particularly in A2780 cells (15.76 µg/ml and 9.11 µg/ml, respectively), while the plant methanolic extract and CHCl3 AgNPs exhibited much higher IC50 values, indicating moderate to low activity. This study highlights the potential of AgNPs in handling anticancer, α-amylase, and antibacterial infections. By assimilating natural products with nanotechnology, it deals an inventive approach to developing targeted, eco-friendly therapies, paving the way for cutting-edge biomedical applications and improved treatment outcomes.

Indexed as

Anti-Bacterial AgentsMetal NanoparticlesSilverAntioxidantsCell Line, TumorEscherichia coliGreen Chemistry TechnologyHumansMicrobial Sensitivity TestsPlant ExtractsPlant LeavesSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAnti-Bacterial AgentsAntioxidantsPlant ExtractsSilver

Identifiers

PMID40587502
PMCPMC12208411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.